date,title,source
Oct-17-18,"The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise",Benzinga
Oct-17-18,"ArQule to Report Third Quarter 2018 Financial Results on October 31, 2018",Business Wire
Oct-19-18,"New Research Coverage Highlights TIER REIT, Meridian Bioscience, ArQule, Greenlight Capital Re, ADT, and Turquoise Hill Resources  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-19-18,"ArQule Presents Orphan Disease Clinical Data at the American Society of Human Genetics (ASHG) 2018 Annual Meeting for Its pan-AKT Inhibitor, Miransertib (ARQ 092)",Business Wire
